BrukervsJohnson & Johnson

BRKR and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

BRKR

Bruker Corporation

$61.36

Value $9.3B

+1.22%
BRKR's page

Bruker (BRKR) has a market value of $9.3B and Johnson & Johnson (JNJ) $672B. Over the last year, with dividends, BRKR moved +48.1% and JNJ +45.4%. Dividend yield: BRKR 0.33%, JNJ 1.89%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BRKR$9.3B

    JNJ$672B

    JNJ is 72 times BRKR

  • Revenue, 12 months

    BRKR$3.5B

    JNJ$99.3B

    JNJ is 28 times BRKR

  • Net income, 12 months

    BRKR-$123M

    JNJ$16.1B

  • Operating margin

    BRKR-2.0%

    JNJ–

  • ROIC

    BRKR-1.3%

    JNJ12.4%

    13.7 points apart

  • P/E

    BRKR–

    JNJ41.7

  • Dividend yield

    BRKR0.3%

    JNJ1.9%

    1.6 points apart

  • 5-year return

    BRKR-25.5%

    JNJ+97.0%

    122.5 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BRKR-25.5%

JNJ+97.0%

5010015020020222023202420252026
Returns by period
PeriodBRKRWith dividendsJNJWith dividends
1 year since November 14, 2025+48.1%Price +47.4%+45.4%Price +42.2%
3 years since November 17, 2023+1.3%+0.4% a yearPrice +0.1%+102.6%+26.5% a yearPrice +86.1%
5 years since November 16, 2021-25.5%-5.7% a yearPrice -26.8%+97.0%+14.5% a yearPrice +71.3%
10 years since November 17, 2016+175.5%+10.7% a yearPrice +164.9%+213.7%+12.1% a yearPrice +139.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BRKRBrukerJNJJohnson & Johnson

Valuation

BRKRJNJ
Valuation
Price$61.36$278.70
Market value$9.3B$672B
Enterprise value (EV)$10.9B$699B
P/E–41.7
P/E, 5-year median40.421.9
P/B4.18.2
EV/EBIT–39.4
Free cash flow yield2.6%3.1%

Results and growth

BRKRJNJ
Results and growth
Revenue, 12 months$3.5B$99.3B
Net income, 12 months-$123M$16.1B
Free cash flow, 12 months$245M$20.6B
Earnings per share, 12 months-$1.10$6.59
Revenue growth, year on year2.1%6.1%
Revenue growth a year, past+11.6%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

BRKRJNJ
Margins and returns on capital
Gross margin47.7%67.6%
Operating margin-2.0%–
Net margin-3.5%16.2%
ROIC-1.3%12.4%
ROE-5.1%19.7%

Balance sheet

BRKRJNJ
Balance sheet
Cash$120M$17.2B
Total debt$1.7B$44.7B
Net debt / EBITDA10.61.1
Interest cover-1.2×18.0×

Dividends and buybacks

BRKRJNJ
Dividends and buybacks
Dividend yield0.3%1.9%
Dividend per share, 12 months$0.20$5.28
Dividend growth a year, past-1.4%over 5 years+5.3%over 5 years
Buyback yield0.1%0.9%
Shareholder yield0.4%2.8%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BRKR or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Bruker or Johnson & Johnson?

By market value, Johnson & Johnson ($672B) is about 71.9 times Bruker ($9.3B), at today's prices.

How did BRKR and JNJ stock do over the last 10 years?

Since November 17, 2016, BRKR's price moved +164.9% and JNJ's +139.1%. With dividends: BRKR +175.5% (+10.7% a year), JNJ +213.7% (+12.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, BRKR or JNJ?

The dividend yield at today's price is 0.33% for Bruker and 1.89% for Johnson & Johnson. Over the last twelve months they paid $0.20 and $5.28 per share.

Which has the higher profit margins, Bruker or Johnson & Johnson?

Over the last twelve months, the net margin was -3.5% for Bruker and 16.2% for Johnson & Johnson, and the operating margin -2.0% and –. Revenue was $3.5B and $99.3B.

Which is the better investment, Bruker or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.